首页 | 本学科首页   官方微博 | 高级检索  
检索        

神经妥乐平肌内注射治疗神经源性疼痛的临床观察
引用本文:何睿林,蒋宗滨,黎承润,唐秀行,唐小松.神经妥乐平肌内注射治疗神经源性疼痛的临床观察[J].中国疼痛医学杂志,2007,13(2):76-78.
作者姓名:何睿林  蒋宗滨  黎承润  唐秀行  唐小松
作者单位:广西医科大学第一附属医院,广西医科大学疼痛医学中心,南宁,530007
摘    要:目的:观察神经妥乐平肌内注射治疗神经源性疼痛的疗效。方法:20例神经源性疼痛患者,以神经妥乐平3.6U/次,肌内注射,2次/d,连续14d为1疗程,记录治疗前后患者VAS评分以及不良反应。结果:所有患者治疗14d后VAS评分较治疗前明显降低;伴随症状改善明显,未出现明显不良反应。结论:神经妥乐平注射治疗神经源性疼痛有效、安全、简便。

关 键 词:神经妥乐平  肌内注射  神经痛

INVESTIGATION OF THE MANAGEMENT OF NEUROPATHIC PAIN USING NEUROTROPIN BY INTRAMUSCULAR INJECTION
HE Rui-Lin,JIANG Zong-Bin,LI Cheng-Run,TANG Xiu-Xing,TANG Xiao-Song.INVESTIGATION OF THE MANAGEMENT OF NEUROPATHIC PAIN USING NEUROTROPIN BY INTRAMUSCULAR INJECTION[J].Chinese Journal of Pain Medicine,2007,13(2):76-78.
Authors:HE Rui-Lin  JIANG Zong-Bin  LI Cheng-Run  TANG Xiu-Xing  TANG Xiao-Song
Institution:The First Filiated Hospital of The Guangxi Medical University,The Centre of Pain Medicine of Guangxi Medical University, Nanning 530007
Abstract:Objectives: To assess the management of neuropathic pain using neurotropin by intramuscular injection.Methods: 40 patients with neuropathic pain were randomly divided into two groups.The control group only adminatrated with Celebrex at dosage of 0.2 g twice daily,and the trial group receiving nerotropnin at dosage of 3.6 U by intramuscular injection twice daily,the course of treatment both were 14 days.Results: The value of VAS decreased significantly after administration compared with pretreatment in all of the patients,and their simultaneous phenomenon improved markedly without apparent adverse reactions.Conclusion: The results suggest that it is effective,safe and convenient on the management of neuropathic pain using neurotropin by intramuscular injection.
Keywords:Neurotropin  Intramuscular injection  Neuropathic pain
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国疼痛医学杂志》浏览原始摘要信息
点击此处可从《中国疼痛医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号